PE20090639A1 - Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidina - Google Patents
Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidinaInfo
- Publication number
- PE20090639A1 PE20090639A1 PE2008001590A PE2008001590A PE20090639A1 PE 20090639 A1 PE20090639 A1 PE 20090639A1 PE 2008001590 A PE2008001590 A PE 2008001590A PE 2008001590 A PE2008001590 A PE 2008001590A PE 20090639 A1 PE20090639 A1 PE 20090639A1
- Authority
- PE
- Peru
- Prior art keywords
- polymorphic forms
- benzofuranil
- carbonylaminomethyl
- fluorophenyl
- thiazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A FORMAS POLIMORFICAS DE (S)-2-((4-BENZOFURANIL)CARBONILAMINOMETIL)-1-((4-(2-METIL-5-(4-FLUOROFENIL))TIAZOLIL)CARBONIL)PIPERIDINA TAL COMO: A) LA FORMA 1 QUE TIENE UN PATRON DE DIFRACCION DE RAYOS X DE POLVO EXPRESADOS EN GRADOS 2 TETA DE 8,0; 9,1; 13,4; 14,1; 18,9; 20,2; ENTRE OTROS; B) LA FORMA 2 QUE TIENE UN PATRON DE DIFRACCION DE RAYOS X DE POLVO EXPRESADOS EN GRADOS 2 TETA DE 7,6; 9,9; 11,1; 13,1; 15,8; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE LA FORMA POLIMORFICA Y A PROCEDIMIENTOS DE PREPARACION DE DICHAS FORMAS POLIMORFICAS LA CUAL ES UTIL PARA EL TRATAMIENTO DE TRASTORNOS DE SUENO TALES COMO INSOMNIO PRIMARIO, HIPERSOMNIO PRIMARIO, NARCOLEPSIA, TRASTORNOS NEUROLOGICOS, DOLORES NEUROPATICOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0717882.5A GB0717882D0 (en) | 2007-09-13 | 2007-09-13 | Novel pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090639A1 true PE20090639A1 (es) | 2009-06-25 |
Family
ID=38658914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001590A PE20090639A1 (es) | 2007-09-13 | 2008-09-11 | Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidina |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100286201A1 (es) |
EP (1) | EP2190842A1 (es) |
JP (1) | JP2010539133A (es) |
KR (1) | KR20100057035A (es) |
CN (1) | CN101801968A (es) |
AR (1) | AR068414A1 (es) |
AU (1) | AU2008297126A1 (es) |
BR (1) | BRPI0816757A2 (es) |
CA (1) | CA2699472A1 (es) |
CL (1) | CL2008002688A1 (es) |
CO (1) | CO6260068A2 (es) |
CR (1) | CR11306A (es) |
DO (1) | DOP2010000066A (es) |
EA (1) | EA201070361A1 (es) |
GB (1) | GB0717882D0 (es) |
MA (1) | MA31692B1 (es) |
MX (1) | MX2010002895A (es) |
PE (1) | PE20090639A1 (es) |
TW (1) | TW200927748A (es) |
UY (1) | UY31337A1 (es) |
WO (1) | WO2009034133A1 (es) |
ZA (1) | ZA201001083B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120101110A1 (en) * | 2010-10-26 | 2012-04-26 | Sangamesh Badiger | Diaza-spiro[5.5]undecanes |
EP3454857A1 (en) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60110066T2 (de) * | 2000-06-16 | 2006-02-02 | Smithkline Beecham P.L.C., Brentford | Piperidine zur verwendung als orexinrezeptorantagonisten |
US20060178307A1 (en) * | 2005-01-26 | 2006-08-10 | The Regents Of The University Of California | Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor |
-
2007
- 2007-09-13 GB GBGB0717882.5A patent/GB0717882D0/en not_active Ceased
-
2008
- 2008-09-10 CL CL2008002688A patent/CL2008002688A1/es unknown
- 2008-09-11 JP JP2010524487A patent/JP2010539133A/ja not_active Withdrawn
- 2008-09-11 KR KR1020107005447A patent/KR20100057035A/ko not_active Application Discontinuation
- 2008-09-11 MX MX2010002895A patent/MX2010002895A/es unknown
- 2008-09-11 CN CN200880106870A patent/CN101801968A/zh active Pending
- 2008-09-11 EP EP08804029A patent/EP2190842A1/en not_active Withdrawn
- 2008-09-11 WO PCT/EP2008/062064 patent/WO2009034133A1/en active Application Filing
- 2008-09-11 TW TW097134783A patent/TW200927748A/zh unknown
- 2008-09-11 CA CA2699472A patent/CA2699472A1/en not_active Abandoned
- 2008-09-11 US US12/677,614 patent/US20100286201A1/en not_active Abandoned
- 2008-09-11 BR BRPI0816757 patent/BRPI0816757A2/pt not_active IP Right Cessation
- 2008-09-11 AU AU2008297126A patent/AU2008297126A1/en not_active Abandoned
- 2008-09-11 PE PE2008001590A patent/PE20090639A1/es not_active Application Discontinuation
- 2008-09-11 EA EA201070361A patent/EA201070361A1/ru unknown
- 2008-09-11 UY UY31337A patent/UY31337A1/es unknown
- 2008-09-11 AR ARP080103950A patent/AR068414A1/es not_active Application Discontinuation
-
2010
- 2010-02-15 ZA ZA201001083A patent/ZA201001083B/xx unknown
- 2010-02-26 DO DO2010000066A patent/DOP2010000066A/es unknown
- 2010-03-05 MA MA32671A patent/MA31692B1/fr unknown
- 2010-03-10 CR CR11306A patent/CR11306A/es unknown
- 2010-03-15 CO CO10030406A patent/CO6260068A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20100057035A (ko) | 2010-05-28 |
CR11306A (es) | 2010-04-20 |
TW200927748A (en) | 2009-07-01 |
ZA201001083B (en) | 2010-10-27 |
CN101801968A (zh) | 2010-08-11 |
MX2010002895A (es) | 2010-04-01 |
CL2008002688A1 (es) | 2009-11-27 |
AR068414A1 (es) | 2009-11-18 |
AU2008297126A1 (en) | 2009-03-19 |
UY31337A1 (es) | 2009-04-30 |
MA31692B1 (fr) | 2010-09-01 |
EA201070361A1 (ru) | 2010-08-30 |
GB0717882D0 (en) | 2007-10-24 |
WO2009034133A1 (en) | 2009-03-19 |
EP2190842A1 (en) | 2010-06-02 |
DOP2010000066A (es) | 2010-04-15 |
CO6260068A2 (es) | 2011-03-22 |
US20100286201A1 (en) | 2010-11-11 |
JP2010539133A (ja) | 2010-12-16 |
CA2699472A1 (en) | 2009-03-19 |
BRPI0816757A2 (pt) | 2015-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2142193T3 (pl) | 1-[2-(2,4-demetylofenylosulfanylo)fenylo]piperazyna jako związek z połączonym wychwytem zwrotnym serotoniny, aktywnością względem 5HT3 i 5-HT1A do leczenia bólu lub rezydualnych objawów depresji związanych ze snem i procesami poznawczymi | |
CL2008001921A1 (es) | Compuestos derivados de heterociclos sustituidos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como ictus, isquemia cerebral, alzheimer, dolor, entre otras. | |
LU92550I2 (fr) | Lurasidone, facultativement sous forme de sa base libre ou de ses sels pharmaceutiquement acceptables | |
CL2007002610A1 (es) | Compuestos derivados de bipiridina sustituida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o la profilaxis de enfermedades tales como hipertonia, diabetes, infarto de miocardio, entre otras. | |
IL213259A0 (en) | Composition for the use to treat alzheimer's disease | |
BR112012018386A2 (pt) | "inibidores isoindolinona de fosfatidilinositol 3-quinase" | |
CL2008003593A1 (es) | Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
PE20121820A1 (es) | (2s,3r)-n-(2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il)benzofuran-2-carboxamida, formas de sales novedosas de ella, y metodos de uso de ella | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
CL2007001030A1 (es) | Compuestos derivados de heterociclilguanidina; y composicion farmaceutica, util para el tratamiento de la enfermedad de alzheimer, demencia senil y demencia asociada a enfermedad de parkinson entre otras. | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
CR20120058A (es) | Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina | |
CR9848A (es) | Combinacion de rosiglitazona y donepezil para mejorar la funcion cognitiva | |
MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
PE20110119A1 (es) | Asociacion entre ferroquina y artesunato para el tratamiento del paludismo | |
CL2015001615A1 (es) | Una composicion farmaceutica que comprende vortioxetina y donepezilo junto con un excipiente farmaceuticamente aceptable; y su uso para el tratamiento de disfuncion cognitiva, demencia en la enfermedad de alzheimer, disfuncion cognitiva asociada a la depresion y a la esquizofrenia, entre otras enfermedades. | |
CL2008000610A1 (es) | Composicion en forma de dosificacion transdermica o transmucosa que comprende una relacion en peso de buprenorfina a naloxona entre 2,1:1 y 8:1, util para el tratamiento del dolor. | |
CL2007003190A1 (es) | Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras. | |
DOP2010000317A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
CL2012000097A1 (es) | Compuestos derivados de 3-fenoximetilpirrolidina, inhibidores de la recaptacion de serotonina-norepinefrina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica que lo comprende; y su uso en el tratamiento de trastornos del dolor, depresion, entre otros. | |
CL2014003607A1 (es) | Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer. | |
MX2011008645A (es) | Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa. | |
PE20081801A1 (es) | Formas solidas de un inhibidor de cinasa raf | |
BRPI0610156A2 (pt) | forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |